surmount-1 trial tirzepatide obesity without diabetes weight loss SURMOUNT 1 // Three-Year Obesty & Prevention Outcomes In the SURMOUNT-5 phase 3b

Turton MD, OShea D, Gunn I, Beak SA, Edwards CMB, Meeran K, et al

Between the lines: GLP-1 drugs like Ozempic and Mounjaro are usually covered by insurance when used to treat Type 2 diabetes but many doctors also prescribe them off-label for overweight and obesity, which often isn't covered

Pharmacol Res (2018) 137:21929

A few notes for non-traditional eating windows: If you fast until noon or later, take WLP-1 before your first meal of the day, not at sunrise If you eat a small breakfast and a bigger lunch, lunch may be the better target If you struggle most with afternoon cravings or evening overeating, you can split your dose: one in the morning, one in the early afternoon The goal isn't a clock

Appetite Control for Sustainable Results By mimicking natural appetite-regulating hormones, tirzepatide aids individuals in eating consciously and reducing their overall caloric intake

At this time our providers believe that the use of this medication works best in conjuncture with added B12